# Rollins Inc: financial statements, quarterly

ROL · NYSE · CIK 84839 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rol.md) · [Financials](/companies/rol/financials.md) · [Filings](/companies/rol/filings.md) · [Insiders](/companies/rol/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rol/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [754 d](/filings/0000084839-26-000008.md) | [748](/filings/0000084839-25-000069.md) | [892](/filings/0000084839-25-000087.md) | [916](/filings/0000084839-25-000100.md) | [832 d](/filings/0000084839-26-000008.md) | [823](/filings/0000084839-26-000022.md) | [1,000](/filings/0000084839-26-000040.md) | [1,026](/filings/0000084839-26-000045.md) | [913 d](/filings/0000084839-26-000008.md) | [906](/filings/0000084839-26-000022.md) | [1,079](/filings/0000084839-26-000040.md) | [1,090](/filings/0000084839-26-000045.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [219 d](/filings/0000084839-26-000008.md) | [223](/filings/0000084839-25-000069.md) | [272](/filings/0000084839-25-000087.md) | [275](/filings/0000084839-25-000100.md) | [246 d](/filings/0000084839-26-000008.md) | [251](/filings/0000084839-26-000022.md) | [308](/filings/0000084839-26-000040.md) | [301](/filings/0000084839-26-000045.md) | [274 d](/filings/0000084839-26-000008.md) | [283](/filings/0000084839-26-000022.md) | [335](/filings/0000084839-26-000040.md) | [327](/filings/0000084839-26-000045.md) |
| Operating income | $m | [139 d](/filings/0000084839-26-000008.md) | [132](/filings/0000084839-25-000069.md) | [182](/filings/0000084839-25-000087.md) | [192](/filings/0000084839-25-000100.md) | [151 d](/filings/0000084839-26-000008.md) | [143](/filings/0000084839-26-000022.md) | [198](/filings/0000084839-26-000040.md) | [225](/filings/0000084839-26-000045.md) | [160 d](/filings/0000084839-26-000008.md) | [145](/filings/0000084839-26-000022.md) | [201](/filings/0000084839-26-000040.md) | [223](/filings/0000084839-26-000045.md) |
| Interest expense | $m | [8.3 d](/filings/0000084839-26-000008.md) | [7.7](/filings/0000084839-25-000069.md) | [7.8](/filings/0000084839-25-000087.md) | [7.2](/filings/0000084839-25-000100.md) | [5.0 d](/filings/0000084839-26-000008.md) | [5.8](/filings/0000084839-26-000022.md) | [7.4](/filings/0000084839-26-000040.md) | [7.9](/filings/0000084839-26-000045.md) | [7.4 d](/filings/0000084839-26-000008.md) | [8.9](/filings/0000084839-26-000022.md) | [9.4](/filings/0000084839-26-000040.md) | [10.7](/filings/0000084839-26-000045.md) |
| Income tax | $m | [37.9 d](/filings/0000084839-26-000008.md) | [30.2](/filings/0000084839-25-000069.md) | [45.6](/filings/0000084839-25-000087.md) | [48.3](/filings/0000084839-25-000100.md) | [39.7 d](/filings/0000084839-26-000008.md) | [32.3](/filings/0000084839-26-000022.md) | [49.8](/filings/0000084839-26-000040.md) | [53.9](/filings/0000084839-26-000045.md) | [38.3 d](/filings/0000084839-26-000008.md) | [29.3](/filings/0000084839-26-000022.md) | [45.8](/filings/0000084839-26-000040.md) | [54.7](/filings/0000084839-26-000045.md) |
| Net income | $m | [109 d](/filings/0000084839-26-000008.md) | [94.4](/filings/0000084839-25-000069.md) | [129](/filings/0000084839-25-000087.md) | [137](/filings/0000084839-25-000100.md) | [106 d](/filings/0000084839-26-000008.md) | [105](/filings/0000084839-26-000022.md) | [141](/filings/0000084839-26-000040.md) | [164](/filings/0000084839-26-000045.md) | [116 d](/filings/0000084839-26-000008.md) | [108](/filings/0000084839-26-000022.md) | [144](/filings/0000084839-26-000040.md) | [158](/filings/0000084839-26-000045.md) |
| Diluted EPS | $ per share | not reported | [0.19](/filings/0000084839-25-000069.md) | [0.27](/filings/0000084839-25-000087.md) | [0.28](/filings/0000084839-25-000100.md) | not reported | [0.22](/filings/0000084839-26-000022.md) | [0.29](/filings/0000084839-26-000040.md) | [0.34](/filings/0000084839-26-000045.md) | not reported | [0.22](/filings/0000084839-26-000022.md) | [0.30](/filings/0000084839-26-000040.md) | [0.33](/filings/0000084839-26-000045.md) |
| Basic EPS | $ per share | not reported | [0.19](/filings/0000084839-25-000069.md) | [0.27](/filings/0000084839-25-000087.md) | [0.28](/filings/0000084839-25-000100.md) | not reported | [0.22](/filings/0000084839-26-000022.md) | [0.29](/filings/0000084839-26-000040.md) | [0.34](/filings/0000084839-26-000045.md) | not reported | [0.22](/filings/0000084839-26-000022.md) | [0.30](/filings/0000084839-26-000040.md) | [0.33](/filings/0000084839-26-000045.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [104](/filings/0000084839-25-000024.md) | [113](/filings/0000084839-24-000070.md) | [107](/filings/0000084839-24-000094.md) | [95.3](/filings/0000084839-24-000106.md) | [89.6](/filings/0000084839-26-000008.md) | [201](/filings/0000084839-25-000069.md) | [123](/filings/0000084839-25-000087.md) | [127](/filings/0000084839-25-000100.md) | [100](/filings/0000084839-26-000045.md) | [117](/filings/0000084839-26-000022.md) | [109](/filings/0000084839-26-000040.md) | [129](/filings/0000084839-26-000045.md) |
| Current assets | $m | [407](/filings/0000084839-25-000024.md) | [424](/filings/0000084839-24-000070.md) | [474](/filings/0000084839-24-000094.md) | [487](/filings/0000084839-24-000106.md) | [443](/filings/0000084839-26-000008.md) | [556](/filings/0000084839-25-000069.md) | [538](/filings/0000084839-25-000087.md) | [551](/filings/0000084839-25-000100.md) | [473](/filings/0000084839-26-000045.md) | [514](/filings/0000084839-26-000022.md) | [590](/filings/0000084839-26-000040.md) | [613](/filings/0000084839-26-000045.md) |
| Total assets | $m | [2,595](/filings/0000084839-25-000024.md) | [2,659](/filings/0000084839-24-000070.md) | [2,767](/filings/0000084839-24-000094.md) | [2,816](/filings/0000084839-24-000106.md) | [2,820](/filings/0000084839-26-000008.md) | [2,949](/filings/0000084839-25-000069.md) | [3,180](/filings/0000084839-25-000087.md) | [3,220](/filings/0000084839-25-000100.md) | [3,141](/filings/0000084839-26-000045.md) | [3,160](/filings/0000084839-26-000022.md) | [3,355](/filings/0000084839-26-000040.md) | [3,359](/filings/0000084839-26-000045.md) |
| Current liabilities | $m | [577](/filings/0000084839-25-000024.md) | [592](/filings/0000084839-24-000070.md) | [610](/filings/0000084839-24-000094.md) | [622](/filings/0000084839-24-000106.md) | [645](/filings/0000084839-26-000008.md) | [637](/filings/0000084839-25-000069.md) | [788](/filings/0000084839-25-000087.md) | [713](/filings/0000084839-25-000100.md) | [786](/filings/0000084839-26-000045.md) | [795](/filings/0000084839-26-000022.md) | [938](/filings/0000084839-26-000040.md) | [987](/filings/0000084839-26-000045.md) |
| Total liabilities | $m | [1,440](/filings/0000084839-25-000024.md) | [1,491](/filings/0000084839-24-000070.md) | [1,530](/filings/0000084839-24-000094.md) | [1,498](/filings/0000084839-24-000106.md) | [1,489](/filings/0000084839-26-000008.md) | [1,593](/filings/0000084839-25-000069.md) | [1,736](/filings/0000084839-25-000087.md) | [1,688](/filings/0000084839-25-000100.md) | [1,766](/filings/0000084839-26-000045.md) | [1,779](/filings/0000084839-26-000022.md) | [1,925](/filings/0000084839-26-000040.md) | [1,968](/filings/0000084839-26-000045.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | [395](/filings/0000084839-26-000008.md) | [485](/filings/0000084839-25-000069.md) | [485](/filings/0000084839-25-000087.md) | [486](/filings/0000084839-25-000100.md) | [486](/filings/0000084839-26-000045.md) | [487](/filings/0000084839-26-000022.md) | [487](/filings/0000084839-26-000040.md) | [488](/filings/0000084839-26-000045.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0000084839-26-000008.md) | not reported | [60.0](/filings/0000084839-25-000087.md) | [0.0](/filings/0000084839-25-000100.md) | [124](/filings/0000084839-26-000045.md) | [164](/filings/0000084839-26-000022.md) | [216](/filings/0000084839-26-000040.md) | [240](/filings/0000084839-26-000045.md) |
| Shareholders' equity | $m | [1,156](/filings/0000084839-26-000008.md) | [1,167](/filings/0000084839-25-000087.md) | [1,236](/filings/0000084839-25-000100.md) | [1,318](/filings/0000084839-25-000100.md) | [1,331](/filings/0000084839-26-000045.md) | [1,356](/filings/0000084839-26-000040.md) | [1,444](/filings/0000084839-26-000045.md) | [1,532](/filings/0000084839-26-000045.md) | [1,374](/filings/0000084839-26-000045.md) | [1,382](/filings/0000084839-26-000040.md) | [1,430](/filings/0000084839-26-000045.md) | [1,390](/filings/0000084839-26-000045.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [153 d](/filings/0000084839-26-000008.md) | [127](/filings/0000084839-25-000069.md) | [145 d](/filings/0000084839-25-000087.md) | [147 d](/filings/0000084839-25-000100.md) | [188 d](/filings/0000084839-26-000008.md) | [147](/filings/0000084839-26-000022.md) | [175 d](/filings/0000084839-26-000040.md) | [191 d](/filings/0000084839-26-000045.md) | [165 d](/filings/0000084839-26-000008.md) | [118](/filings/0000084839-26-000022.md) | [173 d](/filings/0000084839-26-000040.md) | [242 d](/filings/0000084839-26-000045.md) |
| Capital expenditure | $m | [11.2 d](/filings/0000084839-26-000008.md) | [7.2](/filings/0000084839-25-000069.md) | [8.7 d](/filings/0000084839-25-000087.md) | [7.5 d](/filings/0000084839-25-000100.md) | [4.2 d](/filings/0000084839-26-000008.md) | [6.8](/filings/0000084839-26-000022.md) | [7.1 d](/filings/0000084839-26-000040.md) | [8.5 d](/filings/0000084839-26-000045.md) | [5.7 d](/filings/0000084839-26-000008.md) | [7.1](/filings/0000084839-26-000022.md) | [6.4 d](/filings/0000084839-26-000040.md) | [6.4 d](/filings/0000084839-26-000045.md) |
| Dividends paid | $m | [72.5 d](/filings/0000084839-26-000008.md) | [72.6](/filings/0000084839-25-000069.md) | [72.6](/filings/0000084839-25-000087.md) | [72.8](/filings/0000084839-25-000100.md) | [80.0 d](/filings/0000084839-26-000008.md) | [79.9](/filings/0000084839-26-000022.md) | [79.5](/filings/0000084839-25-000087.md) | [80.1](/filings/0000084839-25-000100.md) | [88.5 d](/filings/0000084839-26-000008.md) | [87.8](/filings/0000084839-26-000022.md) | [88.1 d](/filings/0000084839-26-000040.md) | [87.2 d](/filings/0000084839-26-000045.md) |
| Share repurchases | $m | [0.1 d](/filings/0000084839-26-000008.md) | [11.3](/filings/0000084839-25-000069.md) | [0.2 d](/filings/0000084839-25-000087.md) | [(0.0) d](/filings/0000084839-25-000100.md) | [0.1 d](/filings/0000084839-26-000008.md) | [14.7](/filings/0000084839-26-000022.md) | [0.0](/filings/0000084839-26-000040.md) | [3.7 d](/filings/0000084839-26-000045.md) | [198 d](/filings/0000084839-26-000008.md) | [22.4](/filings/0000084839-26-000022.md) | [20.0](/filings/0000084839-26-000040.md) | [120 d](/filings/0000084839-26-000045.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [493](/filings/0000084839-24-000070.md) | [493](/filings/0000084839-24-000094.md) | [491](/filings/0000084839-24-000106.md) | [484](/filings/0000084839-25-000069.md) | [484](/filings/0000084839-25-000087.md) | [484](/filings/0000084839-25-000100.md) | [484](/filings/0000084839-26-000022.md) | [485](/filings/0000084839-26-000040.md) | [485](/filings/0000084839-26-000045.md) | [481](/filings/0000084839-26-000022.md) | [481](/filings/0000084839-26-000040.md) | [479](/filings/0000084839-26-000045.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 478,045,280 at 2026-10-12, from the cover of the [10-Q filed 2026-10-22](/filings/0000084839-26-000045.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.